Arthur Higgins Joins Blackstone's Healthcare
June 16, 2010 08:33 AM Eastern Daylight Time
NEW YORK--(EON: Enhanced Online News)--The Blackstone Group (NYSE: BX) today announced that Arthur
J. Higgins, former Chairman of the Board of Management of Bayer HealthCare AG, has joined the firm’s dedicated
healthcare group, Blackstone Healthcare Partners.
At Blackstone, Mr. Higgins will join health care veterans Lodewijk de Vink and Doug Rogers in providing industry
knowledge and expertise to private equity transactions. Blackstone Healthcare Partners is an integral part of the
firm’s global effort in sourcing, analyzing and overseeing investments in pharmaceuticals and medical products.
Blackstone Healthcare Group’s investments include Nycomed, Gerresheimer, Stiefel Laboratories, and Catalent.
Tony James, President and COO of Blackstone, said “With the addition of Arthur Higgins we have further
strengthened Blackstone Healthcare Partners. They offer a unique value to companies wishing to access focused
industry expertise of this group of leading healthcare stars along with capital to fund growth."
Mr. Higgins had been Chairman of the Bayer HealthCare Executive Committee since July 1, 2004, and Chairman of
the Board of Management of Bayer HealthCare AG since January 1, 2006. During his tenure at Bayer, Mr. Higgins
led the restructuring and strengthening of Bayer HealthCare including the acquisition and integration of Schering AG
and the over-the-counter medicines business of Roche.
Mr. Higgins started his career in 1978 in Britain with Bristol-Myers. He subsequently worked for Sandoz (1979 to
1984) and Fisons (1984 to 1987) before moving to Abbott Laboratories in the USA (1987 to 2001), where he held
positions of increasing responsibility in the international and domestic divisions, including a two-year posting in
Germany. He was appointed President of the Pharmaceutical Products Division in Chicago in 1998. In this position,
he was in charge of Abbott's pharmaceuticals business in t